Michael Friess

Michael Friess has filed trades across 8 companies (mainly through SEC (Form 4)), most often in Oralabs Holding Corp, China Green Agriculture, Inc. and Implant Technologies Inc. Between 26 May 2006 and 1 October 2014, the trades on record add up to 36 filings.

In open-market terms, that means 3 purchases worth €17k on one side and 20 sales worth €1.1M on the other. Sales outweigh purchases by €1.1M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 13 option exercises. Since January 2014: no purchases and 1 sale on the market.

The median purchase comes to €6,226.

The newest entry dates from 8 October 2014: an open-market sale of €25k, in Evolutionary Genomics, Inc. The most recent open-market purchase was published on 9 February 2009, 6,481 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.